Skip to main content

Table 2 Analysis of resistance level against antiretroviral drugs

From: HIV drug resistance and HIV transmission risk factors among newly diagnosed individuals in Southwest China

Drug

Drug resistance level

P

N (%)

L

N (%)

I

N (%)

H

N (%)

TDR

N (%)

PIs

 ATV

10 (0.87)

1 (0.09)

0 (0.00)

0 (0.00)

1 (0.09)

 DRV

0 (0.00)

2 (0.17)

0 (0.00)

0 (0.00)

2 (0.17)

 FPV

12 (1.04)

0 (0.00)

1 (0.09)

2 (0.17)

3 (0.26)

 IDV

11 (0.96)

1 (0.09)

0 (0.00)

0 (0.00)

1 (0.09)

 LPV

4 (0.35)

1 (0.09)

1 (0.09)

0 (0.00)

2 (0.17)

 NFV

8 (0.70)

10 (0.87)

3 (0.26)

0 (0.00)

13 (1.13)

 SQV

4 (0.35)

2 (0.17)

0 (0.00)

0 (0.00)

2 (0.17)

 TPV

3 (0.26)

7 (0.61)

0 (0.00)

0 (0.00)

7 (0.61)

NRTIs

 ABC

0 (0.00)

5 (0.43)

0 (0.00)

1 (0.09)

6 (0.52)

 AZT

3 (0.26)

4 0.35)

1 (0.09)

1 (0.09)

6 (0.52)

 D4T

1 (0.09)

7 (0.61)

2 (0.17)

0 (0.00)

9 (0.78)

 DDI

6 (0.52)

4 (0.35)

1 (0.09)

0 (0.00)

5 (0.43)

 FTC

2 (0.17)

0 (0.00)

1 (0.09)

3 (0.26)

4 (0.35)

 3TC

2 (0.17)

0 (0.00)

1 (0.09)

3 (0.26)

4 (0.35)

 TDF

0 (0.00)

2 (0.17)

0 (0.00)

1 (0.09)

3 (0.26)

NNRTIs

 DOR

1 (0.09)

31 (2.69)

0 (0.00)

2 (0.17)

33 (2.87)

 EFV

137 (11.90)

5 (0.43)

4 (0.35)

3 (0.26)

12 (1.04)

 ETR

173 (15.03)

6 (0.52)

4 (0.35)

0 (0.00)

10 (0.87)

 NVP

162 (14.07)

6 (0.52)

2 (0.17)

6 (0.52)

14 (1.22)

RPV

158 (13.73)

19 (1.65)

5 (0.43)

1 (0.09)

25 (2.17)

  1. P potential resistance, L low resistance, I intermediate resistance, H high resistance, ATV atazanavir, DRV darunavir, FPV fosamprenavir, IDV indinavir, LPV Kaletra, NFV nelfinavir, SQV saquinavir, TPV tipranavir, ABC abacavir, AZT zidovudine, D4T stavudine, DDI didanosine, FTC emtricitabine, 3TC lamivudine, TDF tenofovir, DOR doravirine, EFV efavirenz, ETR etravirine, NVP nevirapine, RPV rilpivirine. Drug resistance = L + I + H